Expression of CXCR-4 and CD 133 and it’s Correlation with Prognostic Pathologic Factors in Resectable Oral Squamous Cell Carcinoma: A Research Protocol
Introduction: Cancer Stem Cells (CSCs), known for their self-renewal and resistance to therapy, drive tumour progression, metastasis, and recurrence. Markers such as Cluster of Differentiation 133 (CD133) and CXC Chemokine Receptor-4 (CXCR-4) are linked to poor prognosis in cancers, including Oral S...
Saved in:
| Main Authors: | Nirlipta Swain, Arvind Shridhar Bhake |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-06-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/21101/75424_CE[Ra1]_F(IS)_QC_PF1(HJ_SS)_PFA(IS)_PN(IS).pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
by: Garima Chandrakar, et al.
Published: (2025-01-01) -
Chemokines: humble yet mighty players in the tumour microenvironment
by: Hima Xavier, et al.
Published: (2025-08-01) -
The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer
by: Mengqi Deng, et al.
Published: (2025-03-01) -
ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration
by: Song Chen, et al.
Published: (2024-12-01) -
Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations
by: Xinyu Li, et al.
Published: (2025-06-01)